Clinical Trial Update: A Phase Ib/II Clinical Study in Patients With Refractory Chronic Cough [Phase 1, Phase 2]

View source ↗

Summary

A Phase Ib/II clinical study is underway evaluating a treatment for refractory chronic cough; results are not yet disclosed and status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cough

Snippet

Sponsor: Beijing Tide Pharmaceutical Co., Ltd | Conditions: Refractory Chronic Cough | Phase 1, Phase 2 | Status: UNKNOWN